Table 3.
Acute and long-term toxicity.
| Adverse event | Grade 1 (%) | Grade 2 (%) |
|---|---|---|
| Acute | ||
| Nausea | 5 (21%) | 1 (4%) |
| Vomiting | 2 (8%) | 1 (4%) |
| Diarrhea | 1 (4%) | 0 (0%) |
| Fatigue | 10 (42%) | 2 (8%) |
| Hepatic pain | 2 (8%) | 2 (8%) |
| AST increased | 4 (17%) | 1 (4%) |
| ALT increased | 3 (13%) | 1 (4%) |
| Anemia | 2 (8%) | 0 (0%) |
| Long-term | ||
| Fatigue | 3 (13%) | 1 (4%) |
| Hepatic pain | 2 (8%) | 1 (4%) |
AST: Aspartate aminotransferase, ALT: Alanine aminotransferase.